| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.082 | 0.2 |